Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: time for a sit-down

CM and PTSC(given legal clearances)would control 55%

If Moore is to be believed, they each own 50%, with TPL merely managing licensing.

Whatever the current situation, I humbly suggest that PTSC is now in a position of great strength and I look forward to Goerner maximizing any potential to the benefit of PTSC.

.

.

Be well

Share
New Message
Please login to post a reply